About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

In-Patient Study In Schizophrenic Patients

NCT00197093·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

18–55

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Must have schizophrenia that has been stable for at least three months.
Willing to discontinue current anti-psychotic medications (under supervision) prior to the study.
Willing to live at the study center for a total of 38 days and then return for three follow-up visits.

You may not be if

Taking medications for conditions other than schizophrenia.
History of alcohol or drug abuse within six months of the study, and their alcohol consumption must meet moderate guidelines.

The record

StatusCompleted

PhasePhase 1

Taking part60

StartedSep 2004

UpdatedMay 18, 2009

Conditions

Clareo Health | In-Patient Study In Schizophrenic Patients